Cas no 1382774-60-8 (6-bromo-1-methyl-1H-indole-2-carbaldehyde)
6-bromo-1-methyl-1H-indole-2-carbaldehyde Chemical and Physical Properties
Names and Identifiers
-
- 6-Bromo-1-methylindole-2-carbaldehyde
- 1,6-Dimethyl-1H-indole-2-carbaldehyde
- 1H-INDAZOLE-3-CARBOXYLIC ACID, 6-BROMO-1-METHYL-
- 6-BROMO-1-METHYL-1H-INDAZOLE-3-CARBOXYLIC ACID
- 6-bromo-1-methyl-1H-indole-2-carbaldehyde
- FT-0684657
- PB19419
- RP09503
- SureCN492125
- CS-0232221
- DB-317978
- G59620
- AKOS015996930
- MFCD22689156
- MG-0711
- VJGLQRJZOPPFPO-UHFFFAOYSA-N
- Z1618014769
- 1382774-60-8
- 6-bromo-1-methyl-1h-indole-2-carboxaldehyde
- SCHEMBL9929075
- EN300-1266221
-
- MDL: MFCD22689156
- Inchi: 1S/C10H8BrNO/c1-12-9(6-13)4-7-2-3-8(11)5-10(7)12/h2-6H,1H3
- InChI Key: VJGLQRJZOPPFPO-UHFFFAOYSA-N
- SMILES: BrC1C=CC2C=C(C=O)N(C)C=2C=1
Computed Properties
- Exact Mass: 236.97893g/mol
- Monoisotopic Mass: 236.97893g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 13
- Rotatable Bond Count: 1
- Complexity: 209
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.5
- Topological Polar Surface Area: 22?2
6-bromo-1-methyl-1H-indole-2-carbaldehyde Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Chemenu | CM256358-1g |
6-Bromo-1-methyl-1H-indole-2-carbaldehyde |
1382774-60-8 | 95% | 1g |
$406 | 2021-08-04 | |
| Chemenu | CM256358-1g |
6-Bromo-1-methyl-1H-indole-2-carbaldehyde |
1382774-60-8 | 95% | 1g |
$430 | 2023-02-02 | |
| Apollo Scientific | OR303144-500mg |
6-Bromo-1-methylindole-2-carbaldehyde |
1382774-60-8 | 500mg |
£218.00 | 2024-05-24 | ||
| Apollo Scientific | OR303144-1g |
6-Bromo-1-methylindole-2-carbaldehyde |
1382774-60-8 | 1g |
£435.00 | 2024-05-24 | ||
| Matrix Scientific | 087845-500mg |
6-Bromo-1-methylindole-2-carbaldehyde, >97% |
1382774-60-8 | >97% | 500mg |
$408.00 | 2023-09-09 | |
| Enamine | EN300-1266221-0.05g |
6-bromo-1-methyl-1H-indole-2-carbaldehyde |
1382774-60-8 | 94% | 0.05g |
$153.0 | 2023-07-10 | |
| Enamine | EN300-1266221-0.1g |
6-bromo-1-methyl-1H-indole-2-carbaldehyde |
1382774-60-8 | 94% | 0.1g |
$228.0 | 2023-07-10 | |
| Enamine | EN300-1266221-0.25g |
6-bromo-1-methyl-1H-indole-2-carbaldehyde |
1382774-60-8 | 94% | 0.25g |
$325.0 | 2023-07-10 | |
| Enamine | EN300-1266221-0.5g |
6-bromo-1-methyl-1H-indole-2-carbaldehyde |
1382774-60-8 | 94% | 0.5g |
$512.0 | 2023-07-10 | |
| Enamine | EN300-1266221-1.0g |
6-bromo-1-methyl-1H-indole-2-carbaldehyde |
1382774-60-8 | 94% | 1.0g |
$656.0 | 2023-07-10 |
6-bromo-1-methyl-1H-indole-2-carbaldehyde Related Literature
-
Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
-
Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
-
4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
-
Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
Additional information on 6-bromo-1-methyl-1H-indole-2-carbaldehyde
6-Bromo-1-methyl-1H-indole-2-carbaldehyde (CAS 1382774-60-8): A Versatile Building Block in Organic Synthesis
6-Bromo-1-methyl-1H-indole-2-carbaldehyde (CAS 1382774-60-8) is an important heterocyclic compound that has gained significant attention in pharmaceutical and material science research. This brominated indole derivative serves as a crucial intermediate in the synthesis of various biologically active molecules and functional materials. With the molecular formula C10H8BrNO, this compound combines the reactivity of both bromo-substituted indoles and aldehyde functional groups, making it particularly valuable for synthetic chemists.
The growing interest in indole-based pharmaceuticals has positioned 6-bromo-1-methyl-1H-indole-2-carbaldehyde as a key building block in drug discovery. Recent studies highlight its potential in developing novel kinase inhibitors and GPCR modulators, addressing current research trends in cancer therapy and neurological disorders. The compound's bromine substituent at the 6-position offers excellent opportunities for further functionalization through cross-coupling reactions, while the aldehyde group provides a handle for condensation and nucleophilic addition reactions.
From a synthetic chemistry perspective, 6-bromo-1-methyl-1H-indole-2-carbaldehyde demonstrates remarkable versatility. The indole scaffold is known for its electron-rich nature, allowing for various electrophilic substitution reactions. The methyl group at the 1-position enhances the compound's stability while maintaining its reactivity profile. Researchers frequently employ this compound in Palladium-catalyzed coupling reactions, reductive amination, and heterocycle formation, making it valuable for constructing complex molecular architectures.
The pharmaceutical applications of 6-bromo-1-methyl-1H-indole-2-carbaldehyde extend to several therapeutic areas. Recent publications have explored its use in developing potential anticancer agents, particularly as precursors for tyrosine kinase inhibitors. The compound's structural features allow for effective binding to various enzyme active sites, a property highly sought after in modern drug design. Additionally, its derivatives show promise in neuroprotective applications, aligning with current research into neurodegenerative diseases.
In material science, 6-bromo-1-methyl-1H-indole-2-carbaldehyde contributes to the development of organic electronic materials. The indole core provides excellent electron-donating properties, while the bromine atom facilitates polymerization through coupling reactions. These characteristics make the compound valuable for creating conductive polymers and OLED materials, addressing the growing demand for advanced organic semiconductors.
The synthesis of 6-bromo-1-methyl-1H-indole-2-carbaldehyde typically involves bromination of 1-methyl-1H-indole-2-carbaldehyde using appropriate brominating agents. Recent advancements have focused on developing more efficient and environmentally friendly synthetic routes, reflecting the chemical industry's shift toward green chemistry principles. These improved methods offer higher yields and better selectivity while reducing hazardous byproducts.
Quality control of 6-bromo-1-methyl-1H-indole-2-carbaldehyde requires careful analytical characterization. Standard techniques include HPLC analysis, mass spectrometry, and NMR spectroscopy. The compound typically appears as a light yellow to brown crystalline powder with high purity grades available for research purposes. Proper storage conditions involve protection from light and moisture to maintain stability.
Market demand for 6-bromo-1-methyl-1H-indole-2-carbaldehyde has steadily increased due to its expanding applications. Pharmaceutical companies and research institutions represent the primary consumers, with growing interest from academic laboratories studying heterocyclic chemistry. The compound's commercial availability in various quantities makes it accessible for both small-scale research and larger industrial applications.
Safety considerations for handling 6-bromo-1-methyl-1H-indole-2-carbaldehyde follow standard laboratory protocols for organic compounds. While not classified as highly hazardous, proper personal protective equipment including gloves and safety glasses is recommended. The compound should be used in well-ventilated areas, following all relevant chemical safety guidelines.
Future research directions for 6-bromo-1-methyl-1H-indole-2-carbaldehyde include exploring its potential in catalysis and asymmetric synthesis. The compound's unique structure offers opportunities for developing novel chiral auxiliaries and ligands in transition metal catalysis. Additionally, its application in bioconjugation chemistry represents an emerging area of interest for creating targeted drug delivery systems.
For researchers working with 6-bromo-1-methyl-1H-indole-2-carbaldehyde, recent literature suggests several promising synthetic transformations. These include Suzuki-Miyaura couplings to create extended π-systems, reductive amination for amine derivatives, and condensation reactions to form various heterocycles. The compound's versatility continues to inspire innovative applications across multiple chemistry disciplines.
In conclusion, 6-bromo-1-methyl-1H-indole-2-carbaldehyde (CAS 1382774-60-8) stands as a valuable tool in modern organic synthesis. Its combination of reactive functional groups on a privileged indole scaffold enables diverse chemical transformations with applications ranging from drug discovery to advanced materials. As research into heterocyclic compounds advances, this brominated indole derivative will likely maintain its importance in both academic and industrial settings.
1382774-60-8 (6-bromo-1-methyl-1H-indole-2-carbaldehyde) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)